Global Dendritic Cell Cancer Vaccine Sales Market Report 2021

Global Dendritic Cell Cancer Vaccine Sales Market Report 2021

Table of Contents
1 Dendritic Cell Cancer Vaccine Market Overview
1.1 Dendritic Cell Cancer Vaccine Product Scope
1.2 Dendritic Cell Cancer Vaccine Segment by Type
1.2.1 Global Dendritic Cell Cancer Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 CreaVax
1.2.3 Sipuleucel-T (Provenge)
1.2.4 Others
1.3 Dendritic Cell Cancer Vaccine Segment by Application
1.3.1 Global Dendritic Cell Cancer Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Dendritic Cell Cancer Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Dendritic Cell Cancer Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Dendritic Cell Cancer Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Dendritic Cell Cancer Vaccine Price Trends (2016-2027)
2 Dendritic Cell Cancer Vaccine Estimates and Forecasts by Region
2.1 Global Dendritic Cell Cancer Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Dendritic Cell Cancer Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Dendritic Cell Cancer Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Dendritic Cell Cancer Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Dendritic Cell Cancer Vaccine Estimates and Projections (2016-2027)
2.4.3 China Dendritic Cell Cancer Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Dendritic Cell Cancer Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Dendritic Cell Cancer Vaccine Estimates and Projections (2016-2027)
2.4.6 India Dendritic Cell Cancer Vaccine Estimates and Projections (2016-2027)
3 Global Dendritic Cell Cancer Vaccine Competition Landscape by Players
3.1 Global Top Dendritic Cell Cancer Vaccine Players by Sales (2016-2021)
3.2 Global Top Dendritic Cell Cancer Vaccine Players by Revenue (2016-2021)
3.3 Global Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dendritic Cell Cancer Vaccine as of 2020)
3.4 Global Dendritic Cell Cancer Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Dendritic Cell Cancer Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Dendritic Cell Cancer Vaccine Market Size by Type
4.1 Global Dendritic Cell Cancer Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Dendritic Cell Cancer Vaccine Price by Type (2016-2021)
4.2 Global Dendritic Cell Cancer Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Dendritic Cell Cancer Vaccine Price Forecast by Type (2022-2027)
5 Global Dendritic Cell Cancer Vaccine Market Size by Application
5.1 Global Dendritic Cell Cancer Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Dendritic Cell Cancer Vaccine Price by Application (2016-2021)
5.2 Global Dendritic Cell Cancer Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Dendritic Cell Cancer Vaccine Price Forecast by Application (2022-2027)
6 North America Dendritic Cell Cancer Vaccine Market Facts & Figures
6.1 North America Dendritic Cell Cancer Vaccine Sales by Company
6.1.1 North America Dendritic Cell Cancer Vaccine Sales by Company (2016-2021)
6.1.2 North America Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021)
6.2 North America Dendritic Cell Cancer Vaccine Sales Breakdown by Type
6.2.1 North America Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Dendritic Cell Cancer Vaccine Sales Breakdown by Application
6.3.1 North America Dendritic Cell Cancer Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Dendritic Cell Cancer Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Dendritic Cell Cancer Vaccine Market Facts & Figures
7.1 Europe Dendritic Cell Cancer Vaccine Sales by Company
7.1.1 Europe Dendritic Cell Cancer Vaccine Sales by Company (2016-2021)
7.1.2 Europe Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021)
7.2 Europe Dendritic Cell Cancer Vaccine Sales Breakdown by Type
7.2.1 Europe Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Dendritic Cell Cancer Vaccine Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Dendritic Cell Cancer Vaccine Market Facts & Figures
8.1 China Dendritic Cell Cancer Vaccine Sales by Company
8.1.1 China Dendritic Cell Cancer Vaccine Sales by Company (2016-2021)
8.1.2 China Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021)
8.2 China Dendritic Cell Cancer Vaccine Sales Breakdown by Type
8.2.1 China Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Dendritic Cell Cancer Vaccine Sales Breakdown by Application
8.3.1 China 162 Sales Breakdown by Application (2016-2021)
8.3.2 China 162 Sales Breakdown by Application (2022-2027)
9 Japan Dendritic Cell Cancer Vaccine Market Facts & Figures
9.1 Japan Dendritic Cell Cancer Vaccine Sales by Company
9.1.1 Japan Dendritic Cell Cancer Vaccine Sales by Company (2016-2021)
9.1.2 Japan Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021)
9.2 Japan Dendritic Cell Cancer Vaccine Sales Breakdown by Type
9.2.1 Japan Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Dendritic Cell Cancer Vaccine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Dendritic Cell Cancer Vaccine Market Facts & Figures
10.1 Southeast Asia Dendritic Cell Cancer Vaccine Sales by Company
10.1.1 Southeast Asia Dendritic Cell Cancer Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Dendritic Cell Cancer Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Dendritic Cell Cancer Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India Dendritic Cell Cancer Vaccine Market Facts & Figures
11.1 India Dendritic Cell Cancer Vaccine Sales by Company
11.1.1 India Dendritic Cell Cancer Vaccine Sales by Company (2016-2021)
11.1.2 India Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021)
11.2 India Dendritic Cell Cancer Vaccine Sales Breakdown by Type
11.2.1 India Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Dendritic Cell Cancer Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Dendritic Cell Cancer Vaccine Sales Breakdown by Application
11.3.1 India Dendritic Cell Cancer Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Dendritic Cell Cancer Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Dendritic Cell Cancer Vaccine Business
12.1 Activarti
12.1.1 Activarti Corporation Information
12.1.2 Activarti Business Overview
12.1.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Activarti Dendritic Cell Cancer Vaccine Products Offered
12.1.5 Activarti Recent Development
12.2 Argos Therapeutics
12.2.1 Argos Therapeutics Corporation Information
12.2.2 Argos Therapeutics Business Overview
12.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Products Offered
12.2.5 Argos Therapeutics Recent Development
12.3 SOTIO (Acquired by PPF Group)
12.3.1 SOTIO (Acquired by PPF Group) Corporation Information
12.3.2 SOTIO (Acquired by PPF Group) Business Overview
12.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Products Offered
12.3.5 SOTIO (Acquired by PPF Group) Recent Development
12.4 Bellicum Pharmaceuticals
12.4.1 Bellicum Pharmaceuticals Corporation Information
12.4.2 Bellicum Pharmaceuticals Business Overview
12.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Products Offered
12.4.5 Bellicum Pharmaceuticals Recent Development
12.5 JW CreaGene
12.5.1 JW CreaGene Corporation Information
12.5.2 JW CreaGene Business Overview
12.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 JW CreaGene Dendritic Cell Cancer Vaccine Products Offered
12.5.5 JW CreaGene Recent Development
12.6 DanDrit
12.6.1 DanDrit Corporation Information
12.6.2 DanDrit Business Overview
12.6.3 DanDrit Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 DanDrit Dendritic Cell Cancer Vaccine Products Offered
12.6.5 DanDrit Recent Development
12.7 DCPrime
12.7.1 DCPrime Corporation Information
12.7.2 DCPrime Business Overview
12.7.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 DCPrime Dendritic Cell Cancer Vaccine Products Offered
12.7.5 DCPrime Recent Development
12.8 Elios Therapeutics
12.8.1 Elios Therapeutics Corporation Information
12.8.2 Elios Therapeutics Business Overview
12.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Products Offered
12.8.5 Elios Therapeutics Recent Development
12.9 ImmunoCellular Therapeutics
12.9.1 ImmunoCellular Therapeutics Corporation Information
12.9.2 ImmunoCellular Therapeutics Business Overview
12.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Products Offered
12.9.5 ImmunoCellular Therapeutics Recent Development
12.10 Kiromic
12.10.1 Kiromic Corporation Information
12.10.2 Kiromic Business Overview
12.10.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Kiromic Dendritic Cell Cancer Vaccine Products Offered
12.10.5 Kiromic Recent Development
12.11 Medigene
12.11.1 Medigene Corporation Information
12.11.2 Medigene Business Overview
12.11.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Medigene Dendritic Cell Cancer Vaccine Products Offered
12.11.5 Medigene Recent Development
12.12 Merck
12.12.1 Merck Corporation Information
12.12.2 Merck Business Overview
12.12.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Merck Dendritic Cell Cancer Vaccine Products Offered
12.12.5 Merck Recent Development
12.13 Northwest Biotherapeutics
12.13.1 Northwest Biotherapeutics Corporation Information
12.13.2 Northwest Biotherapeutics Business Overview
12.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Products Offered
12.13.5 Northwest Biotherapeutics Recent Development
12.14 Immutep Limited
12.14.1 Immutep Limited Corporation Information
12.14.2 Immutep Limited Business Overview
12.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Immutep Limited Dendritic Cell Cancer Vaccine Products Offered
12.14.5 Immutep Limited Recent Development
12.15 Dendreon Corporation
12.15.1 Dendreon Corporation Corporation Information
12.15.2 Dendreon Corporation Business Overview
12.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Dendreon Corporation Dendritic Cell Cancer Vaccine Products Offered
12.15.5 Dendreon Corporation Recent Development
12.16 Oncobiomed
12.16.1 Oncobiomed Corporation Information
12.16.2 Oncobiomed Business Overview
12.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Oncobiomed Dendritic Cell Cancer Vaccine Products Offered
12.16.5 Oncobiomed Recent Development
13 Dendritic Cell Cancer Vaccine Manufacturing Cost Analysis
13.1 Dendritic Cell Cancer Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
13.4 Dendritic Cell Cancer Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dendritic Cell Cancer Vaccine Distributors List
14.3 Dendritic Cell Cancer Vaccine Customers
15 Market Dynamics
15.1 Dendritic Cell Cancer Vaccine Market Trends
15.2 Dendritic Cell Cancer Vaccine Drivers
15.3 Dendritic Cell Cancer Vaccine Market Challenges
15.4 Dendritic Cell Cancer Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Dendritic Cell Cancer Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Dendritic Cell Cancer Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Dendritic Cell Cancer Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Dendritic Cell Cancer Vaccine Sales (K Doses) by Region (2016-2021)
Table 5. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Dendritic Cell Cancer Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Dendritic Cell Cancer Vaccine Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Dendritic Cell Cancer Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Dendritic Cell Cancer Vaccine Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Dendritic Cell Cancer Vaccine Sales Share by Company (2016-2021)
Table 14. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Dendritic Cell Cancer Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Dendritic Cell Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dendritic Cell Cancer Vaccine as of 2020)
Table 17. Global Dendritic Cell Cancer Vaccine Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Dendritic Cell Cancer Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Dendritic Cell Cancer Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Dendritic Cell Cancer Vaccine Sales (K Doses) by Type (2016-2021)
Table 22. Global Dendritic Cell Cancer Vaccine Sales Share by Type (2016-2021)
Table 23. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Dendritic Cell Cancer Vaccine Price (USD/Dose) by Type (2016-2021)
Table 25. Global Dendritic Cell Cancer Vaccine Sales Share by Type (2022-2027)
Table 26. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Dendritic Cell Cancer Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Dendritic Cell Cancer Vaccine Price (USD/Dose) by Type (2022-2027)
Table 29. Global Dendritic Cell Cancer Vaccine Sales (K Doses) by Application (2016-2021)
Table 30. Global Dendritic Cell Cancer Vaccine Sales Share by Application (2016-2021)
Table 31. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Dendritic Cell Cancer Vaccine Price (USD/Dose) by Application (2016-2021)
Table 33. Global Dendritic Cell Cancer Vaccine Sales (K Doses) by Application (2022-2027)
Table 34. Global Dendritic Cell Cancer Vaccine Sales Share by Application (2022-2027)
Table 35. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Dendritic Cell Cancer Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Dendritic Cell Cancer Vaccine Price (USD/Dose) by Application (2022-2027)
Table 38. North America Dendritic Cell Cancer Vaccine Sales (K Doses) by Company (2016-2021)
Table 39. North America Dendritic Cell Cancer Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 43. North America Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Dendritic Cell Cancer Vaccine Sales by Type (2022-2027) & (K Doses)
Table 45. North America Dendritic Cell Cancer Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 47. North America Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Dendritic Cell Cancer Vaccine Sales by Application (2022-2027) & (K Doses)
Table 49. North America Dendritic Cell Cancer Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Dendritic Cell Cancer Vaccine Sales (K Doses) by Company (2016-2021)
Table 51. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Dendritic Cell Cancer Vaccine Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Dendritic Cell Cancer Vaccine Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Dendritic Cell Cancer Vaccine Sales (K Doses) by Company (2016-2021)
Table 63. China Dendritic Cell Cancer Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 67. China Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Dendritic Cell Cancer Vaccine Sales by Type (2022-2027) & (K Doses)
Table 69. China Dendritic Cell Cancer Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 71. China Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Dendritic Cell Cancer Vaccine Sales by Application (2022-2027) & (K Doses)
Table 73. China Dendritic Cell Cancer Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Dendritic Cell Cancer Vaccine Sales (K Doses) by Company (2016-2021)
Table 75. Japan Dendritic Cell Cancer Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Dendritic Cell Cancer Vaccine Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Dendritic Cell Cancer Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Dendritic Cell Cancer Vaccine Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Dendritic Cell Cancer Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Dendritic Cell Cancer Vaccine Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Dendritic Cell Cancer Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Dendritic Cell Cancer Vaccine Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Dendritic Cell Cancer Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Dendritic Cell Cancer Vaccine Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Dendritic Cell Cancer Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Dendritic Cell Cancer Vaccine Sales (K Doses) by Company (2016-2021)
Table 99. India Dendritic Cell Cancer Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Dendritic Cell Cancer Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 103. India Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Dendritic Cell Cancer Vaccine Sales by Type (2022-2027) & (K Doses)
Table 105. India Dendritic Cell Cancer Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 107. India Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Dendritic Cell Cancer Vaccine Sales by Application (2022-2027) & (K Doses)
Table 109. India Dendritic Cell Cancer Vaccine Sales Market Share by Application (2022-2027)
Table 110. Activarti Corporation Information
Table 111. Activarti Description and Business Overview
Table 112. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Activarti Dendritic Cell Cancer Vaccine Product
Table 114. Activarti Recent Development
Table 115. Argos Therapeutics Corporation Information
Table 116. Argos Therapeutics Description and Business Overview
Table 117. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Argos Therapeutics Dendritic Cell Cancer Vaccine Product
Table 119. Argos Therapeutics Recent Development
Table 120. SOTIO (Acquired by PPF Group) Corporation Information
Table 121. SOTIO (Acquired by PPF Group) Description and Business Overview
Table 122. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product
Table 124. SOTIO (Acquired by PPF Group) Recent Development
Table 125. Bellicum Pharmaceuticals Corporation Information
Table 126. Bellicum Pharmaceuticals Description and Business Overview
Table 127. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product
Table 129. Bellicum Pharmaceuticals Recent Development
Table 130. JW CreaGene Corporation Information
Table 131. JW CreaGene Description and Business Overview
Table 132. JW CreaGene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. JW CreaGene Dendritic Cell Cancer Vaccine Product
Table 134. JW CreaGene Recent Development
Table 135. DanDrit Corporation Information
Table 136. DanDrit Description and Business Overview
Table 137. DanDrit Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. DanDrit Dendritic Cell Cancer Vaccine Product
Table 139. DanDrit Recent Development
Table 140. DCPrime Corporation Information
Table 141. DCPrime Description and Business Overview
Table 142. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. DCPrime Dendritic Cell Cancer Vaccine Product
Table 144. DCPrime Recent Development
Table 145. Elios Therapeutics Corporation Information
Table 146. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Elios Therapeutics Description and Business Overview
Table 148. Elios Therapeutics Dendritic Cell Cancer Vaccine Product
Table 149. Elios Therapeutics Recent Development
Table 150. ImmunoCellular Therapeutics Corporation Information
Table 151. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. ImmunoCellular Therapeutics Description and Business Overview
Table 153. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product
Table 154. ImmunoCellular Therapeutics Recent Development
Table 155. Kiromic Corporation Information
Table 156. Kiromic Description and Business Overview
Table 157. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Kiromic Dendritic Cell Cancer Vaccine Product
Table 159. Kiromic Recent Development
Table 160. Medigene Corporation Information
Table 161. Medigene Description and Business Overview
Table 162. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Medigene Dendritic Cell Cancer Vaccine Product
Table 164. Medigene Recent Development
Table 165. Merck Corporation Information
Table 166. Merck Description and Business Overview
Table 167. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 168. Merck Dendritic Cell Cancer Vaccine Product
Table 169. Merck Recent Development
Table 170. Northwest Biotherapeutics Corporation Information
Table 171. Northwest Biotherapeutics Description and Business Overview
Table 172. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 173. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product
Table 174. Northwest Biotherapeutics Recent Development
Table 175. Immutep Limited Corporation Information
Table 176. Immutep Limited Description and Business Overview
Table 177. Immutep Limited Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 178. Immutep Limited Dendritic Cell Cancer Vaccine Product
Table 179. Immutep Limited Recent Development
Table 180. Dendreon Corporation Corporation Information
Table 181. Dendreon Corporation Description and Business Overview
Table 182. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 183. Dendreon Corporation Dendr

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global BCG Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Peptide Cancer Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......

Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......

Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......

Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......

Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110

Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......

Global BCG Vaccine Market Research Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300

Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs